We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$2.22B
AUM Growth
+$375M
Cap. Flow
+$293M
Cap. Flow %
13.2%
Top 10 Hldgs %
17.55%
Holding
845
New
119
Increased
485
Reduced
177
Closed
64

Top Buys

Rank Stock Value
1
NOVT icon
Novanta
NOVT
+$18.9M
2
IRBT
iRobot
IRBT
+$18.1M
3
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$18M
4
OII icon
Oceaneering
OII
+$17M
5
DDD icon
3D Systems Corp
DDD
+$10.3M

Top Sells

Rank Stock Value
1
NOC icon
Northrop Grumman
NOC
+$14.9M
2
FTI icon
TechnipFMC
FTI
+$13.5M
3
ARAY icon
Accuray
ARAY
+$10.8M
4
IMMR icon
Immersion
IMMR
+$8.19M
5
XONE
The ExOne Company
XONE
+$4.9M

Sector Composition

Rank Sector Weight
1 Technology 25.66%
2 Industrials 13.74%
3 Healthcare 10.47%
4 Consumer Discretionary 8.12%
5 Financials 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRT icon
351
Alaunos Therapeutics
TCRT
$4.86M
$1.21M 0.05%
1,954
+546
+39% +$392K
WSM icon
352
Williams-Sonoma
WSM
$29.6B
$1.21M 0.05%
46,796
+19,148
+69% +$488K
INO icon
353
Inovio Pharmaceuticals
INO
$69M
$1.21M 0.05%
24,309
+11,860
+95% +$735K
NLY icon
354
Annaly Capital Management
NLY
$17.4B
$1.2M 0.05%
25,170
+660
+3% +$31.3K
SPTN
355
DELISTED
SpartanNash
SPTN
$1.19M 0.05%
44,430
+4,008
+10% +$99.7K
EW icon
356
Edwards Lifesciences
EW
$51.7B
$1.18M 0.05%
31,521
-2,190
-6% -$80.4K
IBRX icon
357
ImmunityBio
IBRX
$8.1B
$1.18M 0.05%
262,014
+75,201
+40% +$356K
CTRA
358
DELISTED
Coterra Energy
CTRA
$1.17M 0.05%
40,912
+21,734
+113% +$597K
HCSG icon
359
Healthcare Services Group
HCSG
$1.53B
$1.16M 0.05%
22,072
+9,720
+79% +$509K
LAZ icon
360
Lazard
LAZ
$4.31B
$1.16M 0.05%
22,061
+9,891
+81% +$474K
AGEN
361
Agenus
AGEN
$290M
$1.16M 0.05%
18,072
+854
+5% +$65.2K
KDNY
362
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.16M 0.05%
30,828
+8,865
+40% +$387K
SWX icon
363
Southwest Gas
SWX
$6.67B
$1.14M 0.05%
14,100
+1,169
+9% +$94.9K
ADAP
364
DELISTED
Adaptimmune Therapeutics
ADAP
$1.13M 0.05%
169,406
-81,739
-33% -$631K
ES icon
365
Eversource Energy
ES
$27.2B
$1.1M 0.05%
17,466
+3,770
+28% +$238K
CPB icon
366
Campbell Soup
CPB
$6.87B
$1.1M 0.05%
22,782
+4,966
+28% +$236K
DBI icon
367
Designer Brands
DBI
$333M
$1.09M 0.05%
51,146
+7,618
+18% +$156K
OGE icon
368
OGE Energy
OGE
$9.71B
$1.09M 0.05%
33,133
+14,657
+79% +$518K
HUBB icon
369
Hubbell
HUBB
$27.2B
$1.08M 0.05%
7,949
+3,510
+79% +$438K
CMG icon
370
Chipotle Mexican Grill
CMG
$41.5B
$1.06M 0.05%
183,900
-64,800
-26% -$387K
AZO icon
371
AutoZone
AZO
$51.1B
$1.04M 0.05%
1,469
-290
-16% -$185K
ILMN icon
372
Illumina
ILMN
$28.4B
$1.03M 0.05%
4,850
+1,621
+50% +$334K
FDS icon
373
Factset
FDS
$10.2B
$1.03M 0.05%
5,327
+2,340
+78% +$449K
PANW icon
374
Palo Alto Networks
PANW
$297B
$1.01M 0.05%
41,874
+23,298
+125% +$567K
SLB icon
375
SLB Ltd
SLB
$75B
$1M 0.05%
14,900
-439
-3% -$28.4K
13 14
15
16 17

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
WI
Winder Investment Singapore $4.4B AUM 8.87% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return

Vident Investment Advisory's Q4 2017 Portfolio in Review

As of Q4 2017, Vident Investment Advisory held 845 positions worth $2.22B, up 20% from $1.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Vident Investment Advisory deployed $293M of net new capital in Q4 2017, opening 119 new positions and adding to 485 existing holdings. Its largest new stake was Novanta: 388,786 shares worth $19.4M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Northrop Grumman, an estimated $14.9M trimmed.

  • Vident Investment Advisory's largest Q4 2017 buy was Novanta: 388,786 shares worth $19.4M.
  • Vident Investment Advisory added most to iRobot in Q4 2017, an estimated $18.1M increase.
  • Vident Investment Advisory's biggest Q4 2017 reduction was Northrop Grumman, cutting an estimated $14.9M.
  • Vident Investment Advisory fully exited TechnipFMC in Q4 2017, selling an estimated $13.5M.
  • Vident Investment Advisory's ten largest holdings make up 18% of its $2.22B portfolio in Q4 2017.
  • Vident Investment Advisory opened 119 new positions and closed 64 in Q4 2017.
  • Vident Investment Advisory's portfolio value rose 20% quarter-over-quarter to $2.22B.

Based on Vident Investment Advisory's 13F filing for Q4 2017, filed 15 Feb 2018.